Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Nucleus Network's 10 Step Guide to conducting Clinical Trials during a time of uncertainty 2020-04-14 21:17
WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection 2020-04-14 08:00
Gracell to Present the First-in-human, Universal TruUCAR™ GC027 Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Annual Meeting 2020-04-13 21:00
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment 2020-04-10 11:39
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis 2020-04-09 15:14
Samsung Biologics named Champion in 2020 CMO Leadership Awards 2020-04-08 20:00
THE.WAVE.TALK raises US$2M 2020-04-07 20:30
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment 2020-04-06 08:00
Gracell Announces China NMPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia 2020-04-03 22:00
ImmuneMed's 'hzVSF,' Used for Treatment of COVID-19 Pneumonia Patients 2020-03-30 21:00
Samsung Biologics expands leadership for CDO business 2020-03-30 21:00
WuXi Biologics Achieved Remarkable Results in 2019 2020-03-26 21:32
WuXi AppTec Reports Strong 2019 Annual Results 2020-03-24 18:56
Novogene unveils intelligent Next Generation Sequencing delivery platform - Falcon 2020-03-24 17:07
Samsung Biologics Adds Greater Expertise and Diversity to Its Board 2020-03-20 20:00
Glucagon Receptor Structures Reveal G protein Specificity Mechanism 2020-03-20 02:00
West China Hospital in Chengdu Donates COVID-19 Test Kits to Georgia 2020-03-17 11:12
EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells 2020-03-17 00:35
Huami Corporation Reports Fourth Quarter and Full Year 2019 Unaudited Financial Results 2020-03-13 18:00
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019 2020-03-13 05:00
1 124 125 126 127 128 222